logo
Cambodia to nominate Trump for Nobel Peace Prize, says deputy PM

Cambodia to nominate Trump for Nobel Peace Prize, says deputy PM

US President Donald Trump also received Nobel Peace Prize nominations from both Pakistan and Israel. (AP pic)
PHNOM PENH : Cambodia will nominate US President Donald Trump for the Nobel Peace Prize, its deputy prime minister said on Friday, following his direct intervention in halting the Southeast Asian country's recent border conflict with Thailand.
Asked via text message to confirm Cambodia's plan to nominate Trump for the prize, Sun Chanthol responded, 'Yes.'
Speaking to reporters earlier in the capital, Phnom Penh, Chanthol thanked Trump for bringing peace and said he deserved to be nominated for the prize, the highest-profile international award given to an individual or organisation deemed to have done the most to 'advance fellowship between nations'.
Pakistan said in June that it would recommend Trump for the Nobel Peace Prize for his work in helping to resolve a conflict with India, and Israeli Prime Minister Benjamin Netanyahu said last month he had nominated Trump for the award.
It was a call by Trump last week that broke a deadlock in efforts to end the heaviest fighting between Thailand and Cambodia in over a decade, leading to a ceasefire negotiated in Malaysia on Monday, Reuters has reported.
Following the truce announcement, White House spokeswoman Karoline Leavitt said in a post on X that Trump made it happen.
'Give him the Nobel Peace Prize!' she said.
At least 43 people have been killed in the intense clashes, which lasted five days and displaced more than 300,000 people on both sides of the border.
'We acknowledge his great efforts for peace,' said Chanthol, also Cambodia's top trade negotiator, adding that his country was also grateful for a reduced tariff rate of 19%.
Washington had initially threatened a tariff of 49%, later reducing it to 36%, a level that would have decimated Cambodia's vital garment and footwear sector, Chanthol told Reuters in an interview earlier on Friday.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China turns to BRICS partner for coffee
China turns to BRICS partner for coffee

Malaysia Sun

time2 hours ago

  • Malaysia Sun

China turns to BRICS partner for coffee

Beijing fast-tracked authorization for nearly 200 Brazilian firms after the US slapped massive tariffs on the countrys products Beijing has authorized nearly 200 Brazilian companies to export coffee to the Chinese market amid escalating trade tensions between the South American nation and the US, according to the Chinese embassy in Brazil. The greenlight follows Washington's decision to impose a hefty tariff on Brazilian coffee and other goods. The 50% tariff, which took effect in late July, targets coffee and meat - two key sectors of Brazil's economy. The move comes amid the broader trade war launched by US President Donald Trump against multiple countries. "China has approved the authorization of 183 new Brazilian coffee companies to export to the Chinese market," the embassy said Saturday in a post, adding that the measure took effect on July 30 and will remain valid for five years. Brazil's Ministry of Industry and Foreign Trade has estimated that 35.9% of exports to the US will be affected by the tariffs, warning that annual losses could reach up to $14.5 billion. During the 2024/2025 crop year, Brazil exported 7.468 million bags of coffee to the US, making it the largest destination for Brazilian coffee exports, according to the Brazilian Coffee Exporters Council. The US accounted for 16.4% of Brazil's total coffee exports. In monetary terms, that amounted to $1.9 billion in coffee exports, along with $1.35 billion worth of meat. READ MORE: The BRICS hit back: Trumps old tricks meet new world China's growing appetite for coffee appears to align with its latest move to expand imports from Brazil. According to data from the International Coffee Organization, coffee consumption in China grew by 15% in the latest season. At the same time, the number of branded coffee shops in the country surged by 58% over the past 12 months, reaching 49,691 outlets, according to market intelligence firm Alegra Group. The rapid expansion signals China's emergence as a key growth market for global coffee producers. Trump has defended the steep tariffs on Brazilian goods, citing what he called a "witch hunt" against former President Jair Bolsonaro, despite the fact that the US ran a $6.8 billion trade surplus with Brazil in 2024. Trump had previously justified his trade policies by claims that he intended to correct trade imbalances. (

Pfizer reports strong Q2 revenue
Pfizer reports strong Q2 revenue

The Star

time2 hours ago

  • The Star

Pfizer reports strong Q2 revenue

NEW YORK, Aug. 5 (Xinhua) -- U.S. pharmaceutical company Pfizer announced its second-quarter earnings on Tuesday, reporting a 10 percent year over year operational growth. The financial results posted by the New York-headquartered company represent revenue of 14.7 billion U.S. dollars or 0.51 dollars of earnings per share. In an upward revision of its full-year guidance, Pfizer said it now expects adjusted earnings per share for 2025 to range between 2.90 dollars and 3.10 dollars, compared to its previous forecast of 2.80 dollars to 3.00 dollars. The company maintained its annual revenue projection of 61 billion to 64 billion dollars, reflecting confidence in its underlying business performance. "Our business is performing well and I'm pleased with the progress we achieved in the second quarter," Pfizer Chairman and CEO Albert Bourla said in a statement. Pfizer's strong performance came amid mounting policy pressures from the White House. U.S. President Donald Trump has recently sent letters to 17 pharmaceutical companies, including Pfizer, demanding that they cut prices on all existing medications for Medicaid patients to levels no higher than those in Europe. During Tuesday's earnings call, Bourla acknowledged that the company received the letter from the Trump administration. However, he declined to elaborate on the policy's specific impacts, although he emphasized that discussions with the administration have been "extremely productive." Pfizer's Q2 results were bolstered by rising sales in several key product categories. Its Vyndaqel line of cardiomyopathy treatments showed solid growth, and COVID-19-related products were major contributors.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store